| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JCONREL.2014.11.029 |
| P8608 | Fatcat ID | release_5rsivwn3anh6tak4mv4jgwd7l4 |
| P698 | PubMed publication ID | 25483424 |
| P5875 | ResearchGate publication ID | 269281220 |
| P50 | author | Manuel Mazo | Q37835043 |
| Gregor Fuhrmann | Q56561915 | ||
| Andrea Serio | Q59473233 | ||
| Rekha Nair | Q125309882 | ||
| Molly Stevens | Q15896847 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | extracellular vesicle | Q21097485 |
| P304 | page(s) | 35-44 | |
| P577 | publication date | 2014-12-04 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins | |
| P478 | volume | 205 |
| Q57014480 | Abstract Book: ISEV2017 |
| Q38743388 | Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading |
| Q64257753 | Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1 |
| Q30696706 | Bovine milk-derived exosomes for drug delivery |
| Q33615785 | Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges |
| Q38836585 | Circulating extracellular vesicles: Their role in tissue repair and regeneration |
| Q92637579 | Drug Delivery with Extracellular Vesicles: From Imagination to Innovation |
| Q45158285 | Engineered Exosomes as Vehicles for Biologically Active Proteins |
| Q91962415 | Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine |
| Q90799102 | Engineered extracellular vesicles and their mimetics for clinical translation |
| Q92441044 | Engineering Extracellular Vesicles as Nanotherapeutics for Regenerative Medicine |
| Q52688892 | Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy. |
| Q39230414 | Engineering exosomes as refined biological nanoplatforms for drug delivery |
| Q58699737 | Engineering human megakaryocytic microparticles for targeted delivery of nucleic acids to hematopoietic stem and progenitor cells |
| Q46311969 | Engineering of extracellular vesicles as drug delivery vehicles |
| Q41639578 | Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. |
| Q64246035 | Exosome in Cardiovascular Diseases: A Complex World Full of Hope |
| Q58608410 | Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery |
| Q39122582 | Exosomes in cancer theranostic: Diamonds in the rough |
| Q39106432 | Exosomes participate in the carcinogenesis and the malignant behavior of gastric cancer |
| Q59800422 | Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction |
| Q92069591 | Extracellular Vesicles From Auditory Cells as Nanocarriers for Anti-inflammatory Drugs and Pro-resolving Mediators |
| Q64251799 | Extracellular Vesicles as Biological Shuttles for Targeted Therapies |
| Q98159114 | Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy |
| Q64079747 | Extracellular vesicles in renal physiology and clinical applications for renal disease |
| Q58771312 | Extracellular vesicles protect glucuronidase model enzymes during freeze-drying |
| Q26767267 | Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems |
| Q91606884 | Generation, purification and engineering of extracellular vesicles and their biomedical applications |
| Q91586257 | Gold Nanocluster Extracellular Vesicle Supraparticles: Self-Assembled Nanostructures for Three-Dimensional Uptake Visualization |
| Q26749039 | Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration |
| Q90169663 | Heterologous and cross-species tropism of cancer-derived extracellular vesicles |
| Q59799462 | Human liver stem cell-derived extracellular vesicles enhance cancer stem cell sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN combined modulation |
| Q60934975 | Imaging extracellular vesicles: current and emerging methods |
| Q61799835 | Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs |
| Q38638273 | Mesenteric lymph node stromal cell-derived extracellular vesicles contribute to peripheral de novo induction of Foxp3(+) regulatory T cells. |
| Q92514773 | Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles |
| Q88747170 | Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics |
| Q96127279 | Native and bioengineered extracellular vesicles for cardiovascular therapeutics |
| Q104076005 | Plant exosome like nanovesicles: Emerging therapeutics and drug delivery nanoplatforms |
| Q38848034 | Post isolation modification of exosomes for nanomedicine applications |
| Q39076891 | Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics. |
| Q26746178 | Recent Progress in Light-Triggered Nanotheranostics for Cancer Treatment. |
| Q89976335 | Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications |
| Q33684644 | Role of stem cell-derived exosomes in cancer |
| Q60938171 | Roles and Regulation of Extracellular Vesicles in Cardiovascular Mineral Metabolism |
| Q90721850 | Stem Cell-Derived Extracellular Vesicles and Kidney Regeneration |
| Q89360996 | Strategic design of extracellular vesicle drug delivery systems |
| Q92628160 | Targeted Drug Delivery in Lipid-like Nanocages and Extracellular Vesicles |
| Q64944536 | The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells. |
| Q52581537 | The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications. |
| Q48162156 | Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes |
| Q92832366 | Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy |
| Q91773846 | Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications |
| Q60046410 | mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors |
Search more.